THE INFLUENCE OF THE PRESENCE OF ADENOVIRUS-5 E1A AND E1B SEQUENCES ON THE PATHOLOGY OF RAT EMBRYONIC FIBROBLASTS TRANSFECTED WITH ACTIVATED C-HA-RAS AND V-RAS

被引:3
作者
BOGHAERT, ER [1 ]
AUSTIN, V [1 ]
ZIMMER, SG [1 ]
机构
[1] UNIV KENTUCKY,DEPT MICROBIOL & IMMUNOL,LEXINGTON,KY 40536
关键词
D O I
10.1007/BF01753727
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We compared the pathology of two groups of tumors following implantation of cells enmeshed in alginate beads into the syngeneic rat. The first group of tumors was generated by implanting alginate beads containing cloned embryonic fibroblasts (CREF) that were transfected with activated c-Ha-ras (T24) and v-ras (pH1) (CREF tumors). The second group was created by implantation of CREF cells that were transfected with E1a and E1b of wild type adenovirus type 5 prior to transfection with T24 and pH1 (Wt tumors). Alginate beads were implanted at three different sites in the rat, i.e. subcutaneous in the flank, subcutaneous in the tail and under the renal capsule. Tumorigenicity, invasiveness and metastatic capacity of the transfectant cell lines were determined. The tumor latency period (TLP), the doubling time of the tumors and the metastatic capacity of the cell lines depended on the site of implantation. Invasion was not influenced by site-dependency. Wt tumors were invasive and generally had longer TLP than the CREF tumors. Wt tumors did not metastasize to the lungs as opposed to CREF tumors. We concluded that the genetic background of Wt cells modulated the effect of ras transfection by stretching the TLP and by limiting the metastatic potential to the draining lymph nodes. Malignancy per se was not repressed since no differences in invasive capacity were noticed.
引用
收藏
页码:231 / 243
页数:13
相关论文
共 33 条
[1]   MUTATIONS IN THE E1A GENE OF ADENOVIRUS TYPE-5 ALTER THE TUMORIGENIC PROPERTIES OF TRANSFORMED CLONED RAT EMBRYO FIBROBLAST CELLS [J].
BABISS, LE ;
LIAW, WS ;
ZIMMER, SG ;
GODMAN, GC ;
GINSBERG, HS ;
FISHER, PB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (07) :2167-2171
[2]  
BAISCH H, 1990, INVAS METAST, V10, P193
[3]   RAS GENES [J].
BARBACID, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 :779-827
[4]   RAS ONCOGENES - THEIR ROLE IN NEOPLASIA [J].
BARBACID, M .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1990, 20 (03) :225-235
[5]  
BOGDEN AE, 1981, CANCER, V48, P10, DOI 10.1002/1097-0142(19810701)48:1<10::AID-CNCR2820480105>3.0.CO
[6]  
2-I
[7]  
BOGHAERT ER, 1987, INVAS METAST, V7, P230
[8]  
BOYLAN JF, 1990, ANTICANCER RES, V10, P717
[9]  
COLLARD JG, 1988, CANCER SURV, V7, P691
[10]  
COOPMAN P, 1988, CLIN EXPT METASTASIS, V7, P69